Seeking Alpha

Salix Pharmaceuticals (SLXP): Q4 EPS of -$0.13 beats by $0.01. Revenue of $70M (+15.8%) vs....

Salix Pharmaceuticals (SLXP): Q4 EPS of -$0.13 beats by $0.01. Revenue of $70M (+15.8%) vs. $68M. Guides Q1 EPS, revenue below consensus. Shares -3.2% AH. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs